177 related articles for article (PubMed ID: 25845772)
21. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
McCormack B; Gregoriadis G
Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
[TBL] [Abstract][Full Text] [Related]
22. Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
Miyake K; Irie T; Arima H; Hirayama F; Uekama K; Hirano M; Okamaoto Y
Int J Pharm; 1999 Mar; 179(2):237-45. PubMed ID: 10053216
[TBL] [Abstract][Full Text] [Related]
23. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent.
Kaur N; Puri R; Jain SK
AAPS PharmSciTech; 2010 Jun; 11(2):528-37. PubMed ID: 20333488
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of microemulsion of vinpocetine for transdermal delivery.
Hua L; Weisan P; Jiayu L; Hongfei L
Pharmazie; 2004 Apr; 59(4):274-8. PubMed ID: 15125571
[TBL] [Abstract][Full Text] [Related]
25. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
[TBL] [Abstract][Full Text] [Related]
26. Ternary systems of naproxen with hydroxypropyl-beta-cyclodextrin and aminoacids.
Mura P; Maestrelli F; Cirri M
Int J Pharm; 2003 Jul; 260(2):293-302. PubMed ID: 12842348
[TBL] [Abstract][Full Text] [Related]
27. Hydroxypropyl-beta-cyclodextrin increases the aqueous solubility and stability of pilocarpine prodrugs.
Jarho P; Urtti A; Järvinen T
Pharm Res; 1995 Sep; 12(9):1371-5. PubMed ID: 8570537
[TBL] [Abstract][Full Text] [Related]
28. Investigation of microemulsion system for transdermal delivery of meloxicam.
Yuan Y; Li SM; Mo FK; Zhong DF
Int J Pharm; 2006 Sep; 321(1-2):117-23. PubMed ID: 16876972
[TBL] [Abstract][Full Text] [Related]
29. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
Chang SL; Banga AK
J Pharm Pharmacol; 1998 Jun; 50(6):635-40. PubMed ID: 9680073
[TBL] [Abstract][Full Text] [Related]
30. Development, characterization and evaluation of ginger extract loaded microemulsion: In vitro and Ex vivo release studies.
Akram A; Akhtar N; Waqas MK; Rasul A; Rehman KU; Khan J; Iqbal M; Khan BA
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1873-1877. PubMed ID: 31680086
[TBL] [Abstract][Full Text] [Related]
31. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.
Trapani G; Lopedota A; Boghetich G; Latrofa A; Franco M; Sanna E; Liso G
Int J Pharm; 2003 Dec; 268(1-2):47-57. PubMed ID: 14643976
[TBL] [Abstract][Full Text] [Related]
32. [The complexation of prostaglandin E1 with hydroxylpropyl-beta-cyclodextrin in aqueous solution].
Gu FG; Cui FD; Gao YL
Yao Xue Xue Bao; 2004 Sep; 39(9):742-6. PubMed ID: 15606027
[TBL] [Abstract][Full Text] [Related]
33. [Study on the inclusion compound of qucertin with hydroxypropyl-beta-cyclodextrin].
Shao W; Xie Q; Wang C; Mi G; Wang D
Zhong Yao Cai; 2002 Feb; 25(2):121-3. PubMed ID: 12599411
[TBL] [Abstract][Full Text] [Related]
34. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
Bary AR; Tucker IG; Davies NM
Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
[TBL] [Abstract][Full Text] [Related]
35. Influence of alpha-cyclodextrin and hydroxyalkylated beta-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions.
Siefert B; Keipert S
J Pharm Sci; 1997 Jun; 86(6):716-20. PubMed ID: 9188054
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous absorption and model membrane variations of melatonin in aqueous-based propylene glycol and 2-hydroxypropyl-beta-cyclodextrin vehicles.
Lee BJ; Cui JH; Parrott KA; Ayres JW; Sack RL
Arch Pharm Res; 1998 Oct; 21(5):503-7. PubMed ID: 9875485
[TBL] [Abstract][Full Text] [Related]
37. Transdermal delivery of piroxicam using microemulsions.
Park ES; Cui Y; Yun BJ; Ko IJ; Chi SC
Arch Pharm Res; 2005 Feb; 28(2):243-8. PubMed ID: 15789759
[TBL] [Abstract][Full Text] [Related]
38. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Int J Pharm; 2004 Mar; 271(1-2):155-65. PubMed ID: 15129982
[TBL] [Abstract][Full Text] [Related]
39. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion.
Subramanian N; Ghosal SK; Moulik SP
Drug Dev Ind Pharm; 2005 May; 31(4-5):405-16. PubMed ID: 16093206
[TBL] [Abstract][Full Text] [Related]
40. Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives.
Loukas YL; Vraka V; Gregoriadis G
J Pharm Biomed Anal; 1997 Oct; 16(2):263-8. PubMed ID: 9408842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
